{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:29:42Z","timestamp":1790890182232,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Inorganic Biochemistry"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.jinorgbio.2022.112033","type":"journal-article","created":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T11:50:24Z","timestamp":1666180224000},"page":"112033","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["New mescaline-related N-acylhydrazone and its unsubstituted benzoyl derivative: Promising metallophores for copper-associated deleterious effects relief in Alzheimer's disease"],"prefix":"10.1016","volume":"238","author":[{"given":"Alessandra","family":"Carvalho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara Marinho","family":"Barbosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesica S.","family":"Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phelippe","family":"do Carmo Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Diniz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yraima","family":"Cordeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio O.","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daphne S.","family":"Cukierman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicol\u00e1s A.","family":"Rey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinorgbio.2022.112033_bb0005","first-page":"63","article-title":"Doen\u00e7a De Alzheimer: hip\u00f3teses etiol\u00f3gicas e perspectivas de tratamento","volume":"39","author":"De Falco","year":"2016","journal-title":"Qu\u00edmica Nova"},{"key":"10.1016\/j.jinorgbio.2022.112033_bb0010","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.trci.2018.06.014","article-title":"Inflammation as a central mechanism in Alzheimer's disease","volume":"4","author":"Kinney","year":"2018","journal-title":"Alzheimers Dement (N Y)"},{"issue":"12","key":"10.1016\/j.jinorgbio.2022.112033_bb0015","article-title":"Neuropathological alterations in Alzheimer disease","volume":"3","author":"Serrano-Pozo","year":"2011","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.jinorgbio.2022.112033_bb0020","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3389\/fnagi.2018.00118","article-title":"The physiological roles of amyloid-\u03b2 peptide hint at new ways to treat Alzheimer's disease","volume":"10","author":"Brothers","year":"2018","journal-title":"Front. Aging Neurosci."},{"issue":"3","key":"10.1016\/j.jinorgbio.2022.112033_bb0025","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3233\/JAD-2011-111928","article-title":"Hormesis and amyloid-\u03b2 protein: physiology or pathology?","volume":"29","author":"Morley","year":"2012","journal-title":"J. Alzheimers Dis."},{"issue":"6","key":"10.1016\/j.jinorgbio.2022.112033_bb0030","doi-asserted-by":"crossref","first-page":"577","DOI":"10.2174\/1389203720666190103123434","article-title":"Key peptides and proteins in Alzheimer's disease","volume":"20","author":"Penke","year":"2019","journal-title":"Curr. Protein Pept. Sci."},{"issue":"11","key":"10.1016\/j.jinorgbio.2022.112033_bb0035","doi-asserted-by":"crossref","first-page":"6448","DOI":"10.1073\/pnas.95.11.6448","article-title":"Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins","volume":"95","author":"Lambert","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"s1","key":"10.1016\/j.jinorgbio.2022.112033_bb0040","doi-asserted-by":"crossref","first-page":"S567","DOI":"10.3233\/JAD-179941","article-title":"The amyloid-\u03b2 oligomer hypothesis: beginning of the third decade","volume":"64","author":"Cline","year":"2018","journal-title":"J. Alzheimers Dis."},{"issue":"4","key":"10.1016\/j.jinorgbio.2022.112033_bb0045","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S0162-0134(03)00128-4","article-title":"Coordination abilities of the 1-16 and 1-28 fragments of beta-amyloid peptide towards copper(II) ions: a combined potentiometric and spectroscopic study","volume":"95","author":"Kowalik-Jankowska","year":"2003","journal-title":"J. Inorg. Biochem."},{"issue":"49","key":"10.1016\/j.jinorgbio.2022.112033_bb0050","doi-asserted-by":"crossref","first-page":"9273","DOI":"10.1002\/anie.200904567","article-title":"Pulse EPR spectroscopy reveals the coordination sphere of copper(II) ions in the 1-16 amyloid-beta peptide: a key role of the first two N-terminus residues","volume":"48","author":"Dorlet","year":"2009","journal-title":"Angew. Chem. Int. Ed. Eng."},{"issue":"18","key":"10.1016\/j.jinorgbio.2022.112033_bb0055","doi-asserted-by":"crossref","first-page":"18169","DOI":"10.1074\/jbc.M313572200","article-title":"Copper binding to the amyloid-beta (Abeta) peptide associated with Alzheimer's disease: folding, coordination geometry, pH dependence, stoichiometry, and affinity of Abeta-(1-28): insights from a range of complementary spectroscopic techniques","volume":"279","author":"Syme","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jinorgbio.2022.112033_bb0060","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40035-020-00189-z","article-title":"Current understanding of metal ions in the pathogenesis of Alzheimer's disease","volume":"9","author":"Wang","year":"2020","journal-title":"Transl. Neurodegener."},{"issue":"1","key":"10.1016\/j.jinorgbio.2022.112033_bb0065","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1039\/C8MT00203G","article-title":"Cu and Zn interactions with A\u03b2 peptides: consequence of coordination on aggregation and formation of neurotoxic soluble A\u03b2 oligomers","volume":"11","author":"Rana","year":"2019","journal-title":"Metallomics"},{"issue":"11","key":"10.1016\/j.jinorgbio.2022.112033_bb0070","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1039\/c3mt00161j","article-title":"The effect of Cu(2+) and Zn(2+) on the A\u03b242 peptide aggregation and cellular toxicity","volume":"5","author":"Sharma","year":"2013","journal-title":"Metallomics"},{"issue":"22","key":"10.1016\/j.jinorgbio.2022.112033_bb0075","doi-asserted-by":"crossref","first-page":"15145","DOI":"10.1074\/jbc.M600417200","article-title":"Copper-mediated amyloid-beta toxicity is associated with an intermolecular histidine bridge","volume":"281","author":"Smith","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"14","key":"10.1016\/j.jinorgbio.2022.112033_bb0080","doi-asserted-by":"crossref","first-page":"9998","DOI":"10.1074\/jbc.M113.511345","article-title":"Capturing a reactive state of amyloid aggregates: NMR-based characterization of copper-bound Alzheimer disease amyloid \u03b2-fibrils in a redox cycle","volume":"289","author":"Parthasarathy","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.jinorgbio.2022.112033_bb0085","doi-asserted-by":"crossref","first-page":"4885","DOI":"10.1021\/cr9000176","article-title":"Medicinal inorganic chemistry approaches to passivation and removal of aberrant metal ions in disease","volume":"109","author":"Scott","year":"2009","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jinorgbio.2022.112033_bb0090","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1039\/C5MT00003C","article-title":"Disruption of zinc and copper interactions with A\u03b2(1-40) by a non-toxic, isoniazid-derived, hydrazone: a novel biometal homeostasis restoring agent in Alzheimer's disease therapy?","volume":"7","author":"Hauser-Davis","year":"2015","journal-title":"Metallomics"},{"key":"10.1016\/j.jinorgbio.2022.112033_bb0095","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jinorgbio.2017.02.020","article-title":"A moderate metal-binding hydrazone meets the criteria for a bioinorganic approach towards Parkinson's disease: therapeutic potential, blood-brain barrier crossing evaluation and preliminary toxicological studies","volume":"170","author":"Cukierman","year":"2017","journal-title":"J. Inorg. Biochem."},{"issue":"8","key":"10.1016\/j.jinorgbio.2022.112033_bb0100","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1007\/s00775-018-1606-0","article-title":"Aroylhydrazones constitute a promising class of 'metal-protein attenuating compounds' for the treatment of Alzheimer's disease: a proof-of-concept based on the study of the interactions between zinc(II) and pyridine-2-carboxaldehyde isonicotinoyl hydrazone","volume":"23","author":"Cukierman","year":"2018","journal-title":"J. Biol. Inorg. Chem."},{"issue":"8","key":"10.1016\/j.jinorgbio.2022.112033_bb0105","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1007\/s00775-019-01700-2","article-title":"Impact of pyridine-2-carboxaldehyde-derived aroylhydrazones on the copper-catalyzed oxidation of the M112A PrP","volume":"24","author":"Cukierman","year":"2019","journal-title":"J. Biol. Inorg. Chem."},{"issue":"8","key":"10.1016\/j.jinorgbio.2022.112033_bb0110","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1097\/FBP.0000000000000578","article-title":"The aroylhydrazone INHHQ prevents memory impairment induced by Alzheimer's-linked amyloid-\u03b2 oligomers in mice","volume":"31","author":"De Falco","year":"2020","journal-title":"Behav. Pharmacol."},{"issue":"45","key":"10.1016\/j.jinorgbio.2022.112033_bb0115","doi-asserted-by":"crossref","first-page":"16252","DOI":"10.1039\/D0DT01138J","article-title":"X1INH, an improved next-generation affinity-optimized hydrazonic ligand, attenuates abnormal copper(I)\/copper(II)-\u03b1-Syn interactions and affects protein aggregation in a cellular model of synucleinopathy","volume":"49","author":"Cukierman","year":"2020","journal-title":"Dalton Trans."},{"issue":"1","key":"10.1016\/j.jinorgbio.2022.112033_bb0120","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1021\/acs.inorgchem.1c03598","article-title":"Full Equilibrium picture in aqueous binary and ternary systems involving copper(II), 1-methylimidazole-containing hydrazonic ligands, and the 103\u2013112 human prion protein fragment","volume":"61","author":"Cukierman","year":"2022","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2022.112033_bb0125","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.828654","article-title":"Tridentate N-acylhydrazones as moderate ligands for the potential management of cognitive decline associated with metal-enhanced neuroaggregopathies","volume":"13","author":"Cukierman","year":"2022","journal-title":"Front. Neurol."},{"issue":"10","key":"10.1016\/j.jinorgbio.2022.112033_bb0130","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1021\/acschemneuro.8b00215","article-title":"Dark classics in chemical neuroscience: mescaline","volume":"9","author":"Cassels","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.jinorgbio.2022.112033_bb0135","series-title":"Peyote","first-page":"841","author":"Stork","year":"2014"},{"key":"10.1016\/j.jinorgbio.2022.112033_bb0140","series-title":"CrysAlis PRO. Rigaku Oxford Diffraction","author":"Rigaku","year":"2015"},{"issue":"1","key":"10.1016\/j.jinorgbio.2022.112033_bb0145","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1107\/S1600576715001132","article-title":"Crystal structure determination and refinement via SIR2014","volume":"48","author":"Burla","year":"2015","journal-title":"J. Appl. Crystallogr."},{"issue":"Pt 1","key":"10.1016\/j.jinorgbio.2022.112033_bb0150","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1107\/S2053229614024218","article-title":"Crystal structure refinement with SHELXL","volume":"71","author":"Sheldrick","year":"2015","journal-title":"Acta Crystallogr. C Struct. Chem."},{"issue":"4","key":"10.1016\/j.jinorgbio.2022.112033_bb0155","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1107\/S0021889812029111","article-title":"WinGX and ORTEP for Windows: an update","volume":"45","author":"Farrugia","year":"2012","journal-title":"J. Appl. Crystallogr."},{"issue":"5 Part 1","key":"10.1016\/j.jinorgbio.2022.112033_bb0160","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1107\/S0021889897006638","article-title":"ORTEP-3 for Windows - a version of ORTEP-III with a Graphical User Interface (GUI) by J. Farrugia","volume":"30","author":"Barnes","year":"1997","journal-title":"J. Appl. Crystallogr."},{"issue":"2","key":"10.1016\/j.jinorgbio.2022.112033_bb0165","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1107\/S0021889807067908","article-title":"Mercury CSD 2.0\u2013 new features for the visualization and investigation of crystal structures","volume":"41","author":"Macrae","year":"2008","journal-title":"J. Appl. Crystallogr."},{"key":"10.1016\/j.jinorgbio.2022.112033_bb0170","series-title":"Protein NMR Spectroscopy: Principles and Practice","author":"Cavanagh","year":"2006"},{"issue":"1-3","key":"10.1016\/j.jinorgbio.2022.112033_bb0175","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"7","key":"10.1016\/j.jinorgbio.2022.112033_bb0180","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1021\/acsmedchemlett.5b00157","article-title":"Molecular property design: does everyone get it?","volume":"6","author":"Leeson","year":"2015","journal-title":"ACS Med. Chem. Lett."},{"issue":"2","key":"10.1016\/j.jinorgbio.2022.112033_bb0185","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3109\/10611869808997889","article-title":"Estimation of blood-brain barrier crossing of drugs using molecular size and shape, and H-bonding descriptors","volume":"6","author":"van de Waterbeemd","year":"1998","journal-title":"J. Drug Target."},{"issue":"4","key":"10.1016\/j.jinorgbio.2022.112033_bb0190","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1602\/neurorx.2.4.541","article-title":"Medicinal chemical properties of successful central nervous system drugs","volume":"2","author":"Pajouhesh","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.jinorgbio.2022.112033_bb0195","series-title":"Metal Ions in Biological Systems Volume 36: Interrelations Between Free Radicals and Metal Ions in Life Processes p","first-page":"365","author":"Multhaup","year":"1999"},{"issue":"39","key":"10.1016\/j.jinorgbio.2022.112033_bb0200","doi-asserted-by":"crossref","first-page":"15671","DOI":"10.1039\/C6DT02308H","article-title":"How Zn can impede Cu detoxification by chelating agents in Alzheimer's disease: a proof-of-concept study","volume":"45","author":"Conte-Daban","year":"2016","journal-title":"Dalton Trans."},{"issue":"9","key":"10.1016\/j.jinorgbio.2022.112033_bb0205","doi-asserted-by":"crossref","first-page":"5909","DOI":"10.1021\/acs.analchem.8b00740","article-title":"Ascorbate oxidation by Cu(Amyloid-\u03b2) complexes: determination of the intrinsic rate as a function of alterations in the peptide sequence revealing key residues for reactive oxygen species production","volume":"90","author":"Atri\u00e1n-Blasco","year":"2018","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jinorgbio.2022.112033_bb0210","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1039\/B813398K","article-title":"Bioinorganic chemistry of copper and zinc ions coordinated to amyloid-beta peptide","volume":"7","author":"Faller","year":"2009","journal-title":"Dalton Trans."},{"issue":"1","key":"10.1016\/j.jinorgbio.2022.112033_bb0215","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3390\/biom4010101","article-title":"Effect of metals on kinetic pathways of amyloid-\u03b2 aggregation","volume":"4","author":"Hane","year":"2014","journal-title":"Biomolecules"},{"key":"10.1016\/j.jinorgbio.2022.112033_bb0220","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ab.2015.11.021","article-title":"Protein aggregate turbidity: Simulation of turbidity profiles for mixed-aggregation reactions","volume":"498","author":"Hall","year":"2016","journal-title":"Anal. Biochem."},{"issue":"21","key":"10.1016\/j.jinorgbio.2022.112033_bb0225","doi-asserted-by":"crossref","first-page":"12817","DOI":"10.1074\/jbc.273.21.12817","article-title":"Dramatic aggregation of Alzheimer abeta by Cu(II) is induced by conditions representing physiological acidosis","volume":"273","author":"Atwood","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.jinorgbio.2022.112033_bb0230","doi-asserted-by":"crossref","first-page":"9449","DOI":"10.1038\/s41598-019-45988-1","article-title":"His6, His13, and His14 residues in A\u03b2 1-40 peptide significantly and specifically affect oligomeric equilibria","volume":"9","author":"Przygo\u0144ska","year":"2019","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.jinorgbio.2022.112033_bb0235","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1002\/chem.202004484","article-title":"The aggregation pattern of A\u03b21\u201340 is altered by the presence of N-truncated A\u03b24\u201340 and\/or CuII in a similar way through ionic interactions","volume":"27","author":"Stefaniak","year":"2021","journal-title":"Chem. Eur. J."},{"key":"10.1016\/j.jinorgbio.2022.112033_bb0240","series-title":"Crystal Structure and Hirshfeld Analysis of a Poorly Water Soluble Bis(ligand)copper(II) Complex Containing the Metallophore Pyridine-2-Carboxaldehyde 2-Furoyl Hydrazone","author":"Cukierman","year":"2022"},{"issue":"9","key":"10.1016\/j.jinorgbio.2022.112033_bb0245","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26092711","article-title":"Binding models of copper(II) thiosemicarbazone complexes with human serum albumin: a speciation study","volume":"26","author":"May","year":"2021","journal-title":"Molecules"}],"container-title":["Journal of Inorganic Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0162013422003221?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0162013422003221?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T15:12:24Z","timestamp":1758985944000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0162013422003221"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":49,"alternative-id":["S0162013422003221"],"URL":"https:\/\/doi.org\/10.1016\/j.jinorgbio.2022.112033","relation":{},"ISSN":["0162-0134"],"issn-type":[{"value":"0162-0134","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New mescaline-related N-acylhydrazone and its unsubstituted benzoyl derivative: Promising metallophores for copper-associated deleterious effects relief in Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Inorganic Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinorgbio.2022.112033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112033"}}